Written By Lauren Stanwicks, Anisha Sharma, and Shivaranjani Balamurugan Key Takeaways: * Corporate assignees hold 85 to 87 percent of granted biotech patents in both the USPTO and EPO systems, meaning most protected biotech innovation is owned by companies rather than universities. * The academic share of granted patents varies widely by...
Biotech may be global in ambition, but ecosystems thrive when capital arrives and stays.
A conversation with Dr. Marina Gerner, journalist and author of The Vagina Business
Explore how to identify entrepreneurial academics in biotech using key metrics like startup leadership, patents, and research grants.
This report highlights the leading biotechnology venture capitalists in the Chicagoland area and provides an overview of its biotech investment landscape.
Interview with CEOs of Quorum Bio and Envirobe, two eco-tech and climate-conscious startups that are revolutionizing the NYC biotech scene.
